Validation study of the in vitro skin irritation test with the LabCyte EPI-MODEL24

ATLA Alternatives to Laboratory Animals

Volumn 40, Issue 1, 2012, Pages 33-50

  Kojima, Hajime ^a   Ando, Yoko ^b   Idehara, Kenji ^c   Katoh, Masakazu ^d   Kosaka, Tadashi ^e   Miyaoka, Etsuyoshi ^f   Shinoda, Shinsuke ^g   Suzuki, Tamie ^h   Yamaguchi, Yoshihiro ⁱ   Yoshimura, Isao ^f   Yuasa, Atsuko ^j   Watanabe, Yukihiko ^k   Omori, Takashi ^l  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Aiken Co Ltd   (Japan)

^c DAICEL CORPORATION   (Japan)

^d Japan Tissue Engineering Co Ltd   (Japan)

^e INSTITUTE OF ENVIRONMENTAL TOXICOLOGY   (Japan)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

^g Drug Safety Testing Centre Co Ltd   (Japan)

^h Central Research Development Laboratory Fancl Corporation   (Japan)

ⁱ Kobayashi Pharmaceutical Co   (Japan)

^j FUJIFILM CORPORATION   (Japan)

^k Maruishi Pharmaceutical Co Ltd   (Japan)

^l DOSHISHA UNIVERSITY   (Japan)

more..

Author keywords

In vitro; Interleukin 1 alpha (IL 1 ); MTT; Reconstructed human epidermis; Skin irritation; Validation

Indexed keywords

INTERLEUKIN 1ALPHA; IRRITANT AGENT;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; EPIDERMIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSTRUMENT VALIDATION; PRIORITY JOURNAL; SKIN IRRITATION; SKIN TEST; VALIDATION STUDY;

ANIMALIA;

EID: 84860907247     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119291204000108     Document Type: Article

References (31)

1. Draize, J.H., Woodard, G. & Calvery, H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology & Experimental Therapeutics 82, 377-390.
2. OECD (2002). OECD Guideline for the Testing of Chemicals. No. 404. Acute Dermal Irritation/Corrosion, 13pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd-ilibrary.org/ docserver/download/fulltext/9740401e.pdf?expires=1326212784&id= id&accname=freeContent&checksum=479E6FD0B64BAE98FE63C079EB226F82 (Accessed 10.01.12).
3. Cannon, C.L., Neal, P.J., Southee, J.A., Kubilus, J. & Klausner, M. (1994). New epidermal model for dermal irritancy testing. Toxicology in Vitro 8, 889-891. (Pubitemid 24312806)
4. Ponec, M., Boelsma, E., Weerheim, A., Mulder, A., Bouwstra, J. & Mommaas, M. (2000). Lipid and ultrastructural characterization of reconstructed skin models. International Journal of Pharmaceutics 203, 211-225. (Pubitemid 30627641)
5. ECVAM (2007). Statement on the Validity of Invitro Tests for Skin Irritation, 7pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods, Scientific Advisory Committee. Available at: http://iccvam.niehs.nih.gov/methods/dermal/epiderm/ESAC26-SkinIrritation.pdf (Accessed 10. 01.12).
6. ECVAM (2008). Statement on the Scientific Validity of In-vitro Tests for Skin Irritation Testing, 7pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods, Scientific Advisory Committee. Available at: http://ecvam.jrc.ec.europa.eu/ (Accessed 10.01.12).
7. ECVAM (2009). Statement on the Performance Under UN GHS of Three In-vitro Assays for Skin Irritation Testing and the Adaptation of the Reference Chemicals and Defined Accuracy Values of the ECVAM Skin Irritation Performance Standards, 8pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods, Scientific Advisory Committee. Available at http://ecvam.jrc.ec.europa.eu/ (Accessed 10.01.12).
8. UN (2007). Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Second Revised Edition, 555pp. Geneva, Switzerland: United Nations. Available at: http://www.unece.org/fileadmin/DAM/trans/danger/publi/ ghs/ghs-rev02/English/00e-intro.pdf (Accessed 11.01.12).
9. Fentem, J.H., Briggs, D., Chesné, C., Elliott, G.R., Harbell, J.W., Heylings, J.R., Portes, P., Roguet, R., van de Sandt, J.J. & Botham, P.A. (2001). A prevalidation study on in vitro tests for acute skin irritation. Results and evaluation by the Management Team. Toxicology in Vitro 15, 57-93. (Pubitemid 32226375)
10. Portes, P., Grandidier, M-H., Cohen, C. & Roguet, R. (2002). Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: Follow-up to the ECVAM prevalidation study. Toxicology in Vitro 16, 765-770. (Pubitemid 35356285)
11. Zuang, V., Balls, M., Botham, P.A., Coquette, A., Corsini, E., Curren, R.D., Elliott, G.R., Fentem, J.H., Heylings, J.R., Liebsch, M., Medina, J., Roguet, R., van de Sandt, J.J., Wiemann, C. &Worth, A.P. (2002). Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. The European Centre for the Validation of Alternative Methods Skin Irritation Task Force report 2. ATLA 30, 109-129. (Pubitemid 34174876)
12. Kandárová, H., Liebsch, M., Genschow, E., Gerner, I., Traue, D., Slawik, B. & Spielmann, H. (2004). Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX 21, 107-114. (Pubitemid 39302788)
13. Kandárová, H., Liebsch, M., Gerner, I., Schmidt, E., Genschow, E., Traue, D. & Spielmann, H. (2005). The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests - An assessment of the performance of the optimised test. ATLA 33, 351-367. (Pubitemid 41330271)
14. Cotovio, J., Grandidier, M-H., Portes, P., Roguet, R. & Rubinstenn, G. (2005). The in vitro acute skin irritation of chemicals: Optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. ATLA 33, 329-349. (Pubitemid 41330270)
15. Hoffmann, S. (2006). ECVAM Skin Irritation Validation Study Phase II: Analysis of the Primary Endpoint MTT and the Secondary Endpoint IL-1α, 190pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods. Available at: http://ecvam.jrc.it/ft-doc/ATT00042-s.pdf (Accessed 11.01.12).
16. Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J.H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. &Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. ATLA 35, 559-601. (Pubitemid 351169735)
17. Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. & Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: Selection of test chemicals. ATLA 35, 603-619. (Pubitemid 351169736)
18. Griesinger, C., Barroso, J., Zuan, V., Cole, T., Genschow, E. & Liebsch, M. (2010). Explanatory Background Document to the OECD Draft Test Guideline on In Vitro Skin Irritation Testing, 209pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods.
19. ECVAM (2009). ESAC Statement on the Performance Standards (PS) for In Vitro Skin Irritation Testing Using Reconstructed Human Epidermis, 7pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods, Scientific Advisory Committee. Available at: http://ecvam.jrc.it/publication/ ESAC31-statement-updated-skin-irritation-PS-200909-22.pdf (Accessed 20.01.12).
20. ECH (2010). European Chemicals Agency. Helsinki, Finland: European Chemicals Agency. Available at: http://ec.europa.eu/echa/home-en.html (Accessed 23.01.12).
21. Anon. (2004). Commission Staff Working Document. Timetables for the Phasing-out of Animal Testing in the Framework of the 7th Amendment to the Cosmetics Directive (Council Directive 76/768/EEC), 8pp. Brussels, Belgium: Commission of the European Communities. Available at: http://ec.europa.eu/ consumers/sectors/cosmetics/files/doc/antest/sec-2004-1210-en.pdf (Accessed 23.01.12).
22. OECD (2010). OECD Guideline for the Testing of Chemicals. No. 439. In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, 18pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd-ilibrary.org/docserver/download/fulltext/9743901e.pdf?expires= 1326721637&id=id&accname=freeContent&checksum= DE7DC6821D95D80CB715E855076DACF8 (Accessed 16.01.12).
23. Katoh, M., Hamajima, F., Ogasawara, T. & Hata, K-I. (2009). Assessment of the human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol. Journal of Toxicological Science 34, 327-334.
24. OECD (2005). OECD Series on Testing and Assessment. No. 34. Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment, 96pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/ officialdocuments/displaydocumentpdf/?cote=env/jm/mono(2005)14&doclanguage= en (Accessed 16.01.12).
25. Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A.J., Prieto, P., Sabbioni, E., Scott, L., Worth, A. & Zuang, V. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-472. (Pubitemid 40128842)
26. Rheinwald, J.G. & Green, H. (1975). Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6, 331-344.
27. Green, H. (1978). Cyclic AMP in relation to proliferation of the epidermal cell: New view. Cell 15, 801-811.
28. OECD (1999). OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. No 5. Compliance of Laboratory Suppliers with GLP Principles, 8pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/officialdocuments/ publicdisplaydocumentpdf/?cote=ENV/JM/MONO(99)21&docLanguage=En (Accessed 16.01.12).
29. 15 min-42 hours for the Prediction of Acute Skin Irritation of Chemicals, 43pp. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, European Centre for the Validation of Alternative Methods. Available at: http://ecvam.jrc.it/ft-doc/EPISKIN-SITSOP%20JC%20V13-23%2002%2009.pdf (Accessed 20.01.12).
30. Ale, I.S. & Maibach, H.I. (2008). Mechanisms in irritant and allergic contact dermatitis. In Dermatotoxicology (ed. H. Zhai, K-P. Wilhelm &H.I. Maiback), 7th edn, pp. 159-167. Boca Raton, FL, USA: CRC Press.
31. Coquette, A., Berna, N., Vandenbosch, A., Rosdy, M., De Wever, B. & Poumay, Y. (2003). Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization. Toxicology in Vitro 17, 311-321. (Pubitemid 36627750)